The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
Image provided by Pond Tech
Global climate change has become an increasingly important issue to tackle for both governments and the private sector. At the core of that hesitation is the problem of balancing environmental priorities with economic ones: How can economies built on fossil fuel transition to cleaner, more sustainable alternatives without triggering major disruptions to those same economies?
In the race to answer that all-important question, companies like Pond Technologies Inc. PNDHF POND are developing cutting-edge solutions that could finally nudge those slow-to-transition industries toward more sustainable business models. The Ontario, Canada-based environmental, social and governance (ESG) company has pioneered a unique 3-pronged method for capturing carbon emissions and transforming them into revenue streams using its patented algae-based technology.
Pond Carbon Offers the Leading Scalable Algae-Based Carbon Capture Platform to Enter $6.7 Billion Carbon Market
The foundation of Pond’s innovative business model is its patented algae-based platform. Like trees and other plants, algae “inhales” carbon and other gases from the air and then “exhales” the clean, filtered oxygen humans and other species rely on to breathe. It’s so good at absorbing carbon emissions, in fact, that 1 ton of algae can trap nearly 2 tons of carbon.
As impressive as it is, cultivating enough algae to make a meaningful dent in carbon emissions has been challenging. Existing systems rely on large outdoor ponds that rely on natural sunlight and are exposed to multiple sources of contamination.
In these outdoor systems, algae can only grow to depths of a few inches or so below the surface of the water. Such shallow growth means that constructing an algae farm large enough to capture the emissions of even a single factory would require thousands of acres of land. Even with enough land available, the algae that’s grown could be unusable in many applications because of the contamination that can exist in these outdoor systems.
Those challenges spurred the design of Pond’s unique platform. Rather than outdoor systems, Pond uses tanks fitted with LED lights and sensors — all of which work together to create the optimal growing environment for algae while taking up just a fraction of the land and controlling contamination. These tanks can then be connected directly to factory smokestacks to redirect carbon emissions straight into the algae platform where it’s filtered into clean oxygen.
The compact size makes it easy to scale these algae systems to whatever size a company needs to offset its carbon emissions, making it a cost-effective solution for industry leaders like Associated British Foods ASBFY in the agricultural sector to CSV in the oil and gas sector.
Then, the algae that’s harvested from the tanks can be used to create a wide range of exciting and profitable products. Those algae-based products are where the other branches of Pond’s business model come in.
Pond Naturals — A Vertically Integrated Nutraceutical Supplier in the $417 Billion Global Market
The market for algae products is massive. With multiple strains boasting different but equally impressive benefits, the carbon-capturing plant is also a highly nutritious food source that can be turned into functional foods, health supplements, and other nutraceuticals.
Pond Naturals, the 2nd prong of the algae-based system, is focused on manufacturing and distributing algae-based nutraceuticals. After servicing industrial customers, Pond harvests the algae grown in those tanks and turns it into astaxanthin supplements, vegan-friendly high-protein powders and other consumer health products.
Pond's vertically integrated model enables industries to monetize their waste emissions, reduce their carbon footprint and create sustainable products.
Pond Biotech — Innovating in the $126 Billion Global Recombinant Protein Market
The final prong of Pond’s approach is its biotech solutions. Because algae boast such high amounts of protein and because it’s relatively easy to genetically modify, Pond’s algae platform can provide the raw materials to biopharmaceutical and biotech labs that need to develop protein-based diagnostics and therapeutics.
Unlike the mammalian cell cultures, researchers currently rely on to grow the proteins they use to make life-saving treatments, algae are easier and faster to grow. They can also be modified to express precisely the proteins researchers need for the diagnostic or therapeutic treatments they’re working on. Pond’s unique tank-growing platforms also provide the controlled-growth environment needed to produce safe, high-quality, genetically modified algae.
A recent agreement Pond struck with a Fortune 500 company is a prime example of how all these branches come together. The CAD $1 million ($794,270) deal is an early validator for this division.
The preceding post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.